Walleye Capital
GH icon

Walleye Capital’s Guardant Health GH Stock Holding History

Walleye Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27M Buy
291,926
+37,624
+15% +$3.78M 0.11% 118
2025
Q4 		$26M Buy
254,302
+185,509
+270% +$16.6M 0.08% 203
2025
Q3 		$4.3M Buy
68,793
+67,175
+4,152% +$3.65M 0.02% 1020
2025
Q2 		$84.2K Sell
1,618
-3,260
-67% -$146K ﹤0.01% 3848
2025
Q1 		$208K Sell
4,878
-187,318
-97% -$8.08M ﹤0.01% 3231
2024
Q4 		$5.87M Buy
192,196
+186,767
+3,440% +$5.25M 0.01% 971
2024
Q3 		$125K Sell
5,429
-25,895
-83% -$733K ﹤0.01% 4296
2024
Q2 		$905K Buy
31,324
+16,618
+113% +$387K ﹤0.01% 2957
2024
Q1 		$303K Sell
14,706
-28,449
-66% -$610K ﹤0.01% 3659
2023
Q4 		$1.17M Sell
43,155
-2,541
-6% -$66.7K ﹤0.01% 2221
2023
Q3 		$1.35M Buy
+45,696
New +$1.61M ﹤0.01% 2027
2023
Q2 		– Sell
-10,800
Closed -$310K – 4502
2023
Q1 		$253K Sell
10,800
-13,806
-56% -$394K ﹤0.01% 2265
2022
Q4 		$669K Buy
+24,606
New +$1.13M 0.01% 1256
2022
Q1 		– Sell
-2,734
Closed -$273K – 2392
2021
Q4 		$273K Buy
+2,734
New +$283K 0.01% 1304
2021
Q3 		– Sell
-8,157
Closed -$1.01K – 1676
2021
Q2 		$1.01K Buy
+8,157
New +$1.1M 0.03% 449
2021
Q1 		– Sell
-3,483
Closed -$449 – 1233
2020
Q4 		$449 Sell
3,483
-1,570
-31% -$181K 0.03% 510
2020
Q3 		$565K Buy
+5,053
New +$462K 0.06% 368
2020
Q1 		– Sell
-1,455
Closed -$114K – 1201
2019
Q4 		$114K Buy
+1,455
New +$105K 0.01% 1325

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's GH Position: Q1 2026 in Review

Walleye Capital increased its Guardant Health (GH) stake by 15% in Q1 2026, buying an estimated $3.78M and bringing the position to 291,926 shares worth $27M. The position accounts for 0.11% of the portfolio, ranked #118.

Walleye Capital first reported a position in GH in Q4 2019 and has held it in 18 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Walleye Capital held 291,926 shares of Guardant Health worth $27M as of Q1 2026.
  • Walleye Capital bought 37,624 Guardant Health shares in Q1 2026, an estimated $3.78M.
  • Guardant Health made up 0.11% of Walleye Capital's portfolio in Q1 2026, its #118 holding.
  • Walleye Capital first reported a position in Guardant Health in Q4 2019 and has held it in 18 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.